Viatris (VTRS) EV to CFO (2019 - 2026)
Viatris (VTRS) posted EV to CFO of 45.45 for Q2 2026, up 26.7% on a QoQ basis from 35.87 in Q1 2026, and up 1.43% year-over-year from 44.81 in Q2 2025.
Analysis
Viatris (VTRS) EV to CFO (2019 - 2026) Analysis & Trends
Viatris has reported EV to CFO for 8 years, with the latest figure at 45.45 in Q2 2026.
- On a quarterly basis, EV to CFO rose 1.43% year-over-year to 45.45 in Q2 2026; TTM through Jun 2026 was 7.45, a 56.12% increase from a year earlier, with the FY2025 full-year figure at 5.62, down 8.4% from the prior year.
- EV to CFO was 45.45 for Q2 2026 at Viatris, up from 35.87 in the prior quarter.
- The five-year high for EV to CFO was 63.8 in Q4 2022, with the low at 10.92 in Q1 2022.
- Average EV to CFO over 5 years is 24.3, with a median of 19.28 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: EV to CFO surged 113.12% in 2022, then sank 67.27% in 2023.
- Over 5 years, EV to CFO stood at 63.8 in 2022, then tumbled by 67.27% to 20.88 in 2023, then soared by 40.16% to 29.26 in 2024, then sank by 45.49% to 15.95 in 2025, then jumped by 184.95% to 45.45 in 2026.
- The last three EV to CFO figures came in at 45.45 (Q2 2026), 35.87 (Q1 2026), and 15.95 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.45 |
| Mar 31, 2026 | 35.87 |
| Dec 31, 2025 | 15.95 |
| Sep 30, 2025 | 14.00 |
| Jun 30, 2025 | 44.81 |
| Mar 31, 2025 | 17.68 |
| Dec 31, 2024 | 29.26 |
| Sep 30, 2024 | 14.49 |
| Jun 30, 2024 | 31.05 |
| Mar 31, 2024 | 21.48 |
| Dec 31, 2023 | 20.88 |
| Sep 30, 2023 | 12.59 |
| Jun 30, 2023 | 21.60 |
| Mar 31, 2023 | 11.36 |
| Dec 31, 2022 | 63.80 |
| Sep 30, 2022 | 11.15 |
| Jun 30, 2022 | 14.99 |
| Mar 31, 2022 | 10.92 |
| Dec 31, 2021 | 29.94 |
| Sep 30, 2021 | 14.40 |